Business Context and Reporting Period
This Form 8-K Current Report was filed by Nasdaq, Inc. on November 19, 2021. The filing discloses the execution of a new employment agreement with Adena T. Friedman, the company's President and Chief Executive Officer, effective January 1, 2022.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation terms.
- Base Salary: No less than $1,250,000 annually.
- Target Bonus: No less than $3,000,000 annually, contingent on performance goals.
- One-Time Equity Grant: Non-qualified stock options valued at $10,000,000, to be granted on January 3, 2022.
- Equity Vesting: The one-time grant vests over five years, with 50% contingent on performance conditions.
Material Changes
The new agreement supersedes Ms. Friedman's prior employment agreement dated November 14, 2016. The term of the new agreement is five years (January 1, 2022, to January 1, 2027). A significant change includes the approval of a one-time $10 million stock option grant and the establishment of specific termination payment structures.
Outlook, Risks, and Contingencies
The agreement outlines specific financial contingencies based on termination scenarios:
- Termination Without Cause/Good Reason: Entitles the executive to a cash payment equal to two times the prior year's base salary plus two times the Target Bonus, plus pro-rata bonus. Includes 12 months of continued equity vesting and COBRA premium subsidies for up to 24 months.
- Change in Control ("Double Trigger"): If terminated without cause or for good reason within two years of a change in control, the executive receives the same cash severance (2x salary + 2x bonus) plus accelerated vesting of all outstanding unvested equity and continued life insurance benefits.
- Disability or Death: Entitles the executive or estate to a pro-rata Target Bonus and accelerated vesting of all unvested equity.
- Risks: Termination payments are subject to discontinuation if the executive breaches restrictive covenants (non-compete, non-solicitation) or fails to execute a general release of claims.
Investor Verification Checklist
- Verify the exact grant date and exercise terms of the $10,000,000 stock option award in the Equity Incentive Plan.
- Review the specific performance goals established by the Management Compensation Committee for the Target Bonus and the 50% performance-contingent equity vesting.
- Confirm the full text of the Employment Agreement and Continuing Obligations Agreement when filed as an exhibit to the 2021 Form 10-K.
- Assess the impact of the $10 million grant on future dilution and compensation expense recognition.